The potential use of Cord Blood treatment of heart and lung disorders

Two new studies of animals, published in the current issue of cell transplantation shows that umbilical cord derived stem cells can have whom the heart and lungs.

In one study, carried out at the Samsung Medical Center in Seoul, the researchers found the therapeutic benefit of having non-cord blood mesenchymal stem cells (MSCs) newborn rats with lung injuries from oxygen. Is still a long way before human use but if perfected, this type of treatment may be the first address disease Acne currently untreatable hyperoxic or chronic (BPD), in infants, premature.

The second study in Germany found that autologous indicate (self-donated) umbilical cord mononuclear cells (UCMNCs) in the heart of improved features in sheep on common defects of cyanotic heart defect, replacement procedures, feasible and safe.

The test takes us to yet another step forward, the enlargement of the list of diseases, which could potentially treat the umbilical cord blood and further strengthen Our belief in the importance of banking cord blood – public or private – to use in the future.

Be the first to like this post.Tags: animals, MSCs, UCMNCs

This entry was posted on December 16, 2009 at 9: 18 pm and is filed under the cord blood research. You can track any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback your own site.

cord blood us